Technology | Advanced Visualization | September 20, 2016

Riverain Technologies Earns FDA Approval for ClearRead CT Software

Device offers superior nodule detection performance and faster reading using a concurrent read for lung CT screening

Riverain Technologies, ClearRead CT, lung nodule detection software, FDA approval

September 20, 2016 — Riverain Technologies announced that its ClearRead CT, a breakthrough lung nodule detection application, has received clearance from the U.S. Food and Drug Administration (FDA).

ClearRead CT is the only FDA-cleared device to support concurrent reading, allowing for faster reading with proven superior automatic nodule detection performance for all primary nodule types, including solid, sub-solid and ground glass nodules.

ClearRead CT, powered by acquisition normalization technology, provides an enterprise-ready solution for the entire healthcare network. The technology seamlessly processes computed tomography (CT) scans from a wide range of manufacturers and acquisition protocols, and quickly installs into the clinical environment without the need for new hardware or customized tuning to specific devices or protocols.

ClearRead CT was evaluated in a multi-reader, multi-case clinical trial and showed radiologists achieved a 29 percent reduction in missed actionable nodules, while reducing reading time by 26 percent.

The software is comprised of two tools: ClearRead CT | Vessel Suppress and ClearRead CT | Detect. Deep learning enables the vessel suppression technology to assist both machine and humans in the detection and characterization of all primary nodule types, allowing for previously unattained nodule detection performance.

ClearRead CT is available for sale in the United States, Canada and Europe.

For more information: www.riveraintech.com

Related Content

As part of an international collaboration, researchers from Aarhus University and University of Leicester have succeeded in developing a dynamic 3-D CT scanning method that shows what happens inside the body during simulated heart massage

A look inside cardiopulmonary resuscitation: A 4-D computed tomography model of simulated closed chest compression. A proof of concept. Courtesy of Kasper Hansen/Jonathan Bjerg Moeller/Aarhus University

News | Cardiac Imaging | August 07, 2020
August 7, 2020 — Rapid first aid during...
Mobile CT scanner reimagines head imaging of critically ill patients by enabling patients and staff to remain in ICU
News | Computed Tomography (CT) | August 05, 2020
August 5, 2020 — The Food and Drug Administration (FDA) has cleared the...
Imaging volumes in hospitals and practices previously slowed by the coronavirus pandemic continue to hold steady, according to new QuickPoLL survey results that gauge how radiologists feel about current business and the impact of COVID-19.
Feature | Coronavirus (COVID-19) | August 03, 2020 | By Melinda Taschetta-Millane
Imaging volumes in hospitals and practices previously slowed by the coronavirus pandemic continue to hold steady, acc
A World Health Organization (WHO) rapid advice guide on the use of chest imaging in the diagnosis and management of COVID-19 was published in the journal Radiology.

Getty Images

News | Coronavirus (COVID-19) | July 30, 2020
July 30, 2020 — A World Health Organization (WHO) rapid advice gui
It covers every major modality, including breast imaging/mammography, fixed and portable C-arms (cath, IR/angio, hybrid, OR), CT, MRI, nuclear medicine, radiographic fluoroscopy, ultrasound and X-ray
News | Radiology Imaging | July 29, 2020
July 29, 2020 — IMV Medical Information, part of Scien...
Left, a 3-D rendering of a heart from a cardiac CT exam. Right, a lung-CT exam showing the heart and ground glass lesions in the lungs of a COVID-19 patient. CT has become a front-line imaging modality in the COVID era because it offers both cardiac and lung information to help determine a patients disposition with chest pain, COVID-19 and COVID-caused myocarditis and pulmonary embolism. #COVID19 #CCTfirst #YesCCT

Left, a 3-D rendering of a heart from a cardiac CT exam. Right, a lung-CT exam showing the heart and ground glass lesions in the lungs of a COVID-19 patient. CT has become a front-line imaging modality in the COVID era because it offers both cardiac and lung information to help determine a patients disposition with chest pain, COVID-19 and COVID-caused myocarditis and pulmonary embolism.

Feature | Computed Tomography (CT) | July 28, 2020
July 28, 2020 — The use of cardiova...
ams Commended by United Imaging for Accelerated Supply of Unprecedented Levels of Essential CT Detectors to Fight Covid-19 (SARS-CoV-2)
News | Coronavirus (COVID-19) | July 28, 2020
July 28, 2020 — ams, a leading worldwide supplier of high performance sensor solutions, has been thanked by long-term